Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Filings indexed 422 across all filing types
Latest filing 2020-02-03 Proxy Solicitation & In…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company 'Handok'. It outlines the meeting date, location, and the agenda items (proposals) to be voted on, such as director appointments, articles of incorporation changes, and remuneration limits. This is a standard proxy solicitation document used to inform shareholders of an upcoming meeting and the matters to be decided, which falls under the Proxy Solicitation & Information Statement category.
2020-02-03 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees, including the number of shares, exercise price, vesting conditions, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation falls under the 'Share Issue/Capital Change' category, as it relates to the potential future issuance of shares.
2020-02-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and major contracts (such as collateral agreements) of major shareholders and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the specific terms, conditions, and recipients of stock options granted by Handok Inc. This type of disclosure regarding share-based compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement required by financial authorities that does not fit into the other specialized categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2019-12-11 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 98% confidence The document is a short announcement (672 characters) regarding the scheduling and details of an upcoming Investor Relations (IR) event (Corporate Day). It provides the date, location, and purpose of the meeting, and mentions that the IR materials were published separately. Per the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation itself, and it serves as a regulatory notification of an upcoming corporate activity, it is classified as a Report Publication Announcement (RPA).
2019-12-05 Korean
기업설명회(IR)개최(안내공시)
Regulatory Filings Classification · 95% confidence The document is a short announcement (608 characters) regarding the scheduling of an Investor Relations (IR) event (Corporate Day). It provides the date, time, location, and purpose of the meeting, but does not contain the actual presentation slides or detailed financial data. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Since this is specifically an announcement of an IR event, it fits best under RNS as a general regulatory announcement.
2019-11-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.